What this test measures
A cervical cancer screen panel bundles the two most useful cervical cancer screening tests:
• High-risk HPV DNA test — detects 14 oncogenic HPV types (with separate reporting of HPV 16 and HPV 18). Highly sensitive for detecting pre-cancer. • Pap smear (cervical cytology) — looks at cervical cells under the microscope for abnormalities (ASC-US, LSIL, HSIL, AGC). Highly specific.
A single cervical sample collected via a brush at the cervix in liquid-based cytology medium supports both tests. The panel produces both an HPV result and a cytology result; together they triage women into low-, intermediate- and high-risk categories with specific follow-up paths.
Why it matters
Cervical cancer is one of the most common cancers in Indian women — and one of the most preventable. It is almost entirely caused by persistent infection with high-risk HPV. Screening with HPV testing, with or without Pap cytology, catches pre-cancerous changes (CIN 1–3) that can be treated before they become invasive cancer. WHO's 90-70-90 elimination goals (90% vaccination, 70% screening at 35 & 45, 90% treatment of pre-cancer) shape national strategy.
Co-testing (HPV + Pap) is preferred internationally over either test alone because it combines HPV's sensitivity with Pap's specificity. A negative co-test allows the longest screening interval (5 years) with the highest reassurance.
How to prepare
Schedule the test for a time when you are not menstruating — ideally 10–14 days after the start of your last period. Avoid vaginal intercourse, vaginal medications, douching, spermicides and tampons for 48 hours before the test. The sample is collected by your gynaecologist during a routine pelvic exam (3–5 minutes). Mild spotting after the test is normal. Mention any history of cervical procedures (LEEP, conisation), HPV vaccination, previous abnormal Pap, or current pregnancy.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| HPV (high-risk) (—)[1][2] | Not detected | Not detected — very low risk of pre-cancer. | Detected — increased risk of pre-cancer. HPV 16 or HPV 18 → colposcopy regardless of Pap. Other 12 high-risk types → reflex Pap; colposcopy if Pap abnormal or HPV persists at 12 months. |
| Pap Cytology (Bethesda) (—)[1] | NILM (Negative for Intraepithelial Lesion or Malignancy) | NILM — no abnormal cells. Continue routine screening. | Abnormal categories: ASC-US (atypical squamous cells, undetermined), LSIL (low-grade squamous intraepithelial lesion), HSIL (high-grade), ASC-H (atypical cells, cannot exclude HSIL), AGC (atypical glandular cells), or squamous cell carcinoma / adenocarcinoma. Higher grades require colposcopy + biopsy. |
Co-test results and management
| HPV result | Pap result | Action |
|---|---|---|
| Negative | NILM | Repeat in 5 years |
| Negative | ASC-US | Repeat co-test in 3 years |
| Positive (other 12) | NILM | Repeat co-test in 1 year, OR genotype |
| Positive (HPV 16/18) | Any | Colposcopy |
| Positive | ASC-US or worse | Colposcopy |
| Any | HSIL / ASC-H / AGC / cancer | Immediate colposcopy + biopsy |
Frequently asked questions
When should I start cervical cancer screening?
WHO recommends starting at age 30 with HPV-based screening (earlier in HIV-positive women). ACS recommends starting at 25 with primary HPV testing. Indian ICMR guidance recommends starting at 30 with HPV testing or visual inspection methods where HPV testing is not available.
How often should I do this test?
A negative HPV + Pap co-test allows a 5-year interval (the strongest reassurance). HPV alone allows 5-year intervals in many guidelines. Pap alone (without HPV) is repeated every 3 years.
I am HPV-vaccinated — do I still need screening?
Yes. HPV vaccines protect against the most important high-risk types but not all of them. Screening recommendations are the same for vaccinated and unvaccinated women.
A positive HPV test — does it mean cancer?
No. Most HPV infections clear on their own within 1–2 years without treatment. A positive test triggers closer follow-up. Only persistent infection — especially with HPV 16/18 — substantially raises cancer risk.
What if my Pap shows ASC-US?
ASC-US ("atypical squamous cells of undetermined significance") is a low-grade abnormality. The next step depends on HPV status: HPV-positive → colposcopy; HPV-negative → repeat co-test in 3 years. Many ASC-US findings resolve spontaneously.
How long does the report take?
HPV PCR + cytology results are typically available in 5–7 days.
Is screening painful?
Mildly uncomfortable but not painful for most women. Brief speculum insertion and a quick brush of the cervix; mild spotting afterwards is normal.
Related Oncology / Tumor Markers tests
Tests commonly ordered alongside Cervical Cancer Screen Panel, or that help interpret an unexpected result.
Sources & references
- WHO — Cervical Cancer Elimination Initiative · accessed 2026-05-30T00:00:00.000Z
- American Cancer Society — Cervical Cancer Screening · accessed 2026-05-30T00:00:00.000Z
- NCCN — Cervical Cancer Screening · accessed 2026-05-30T00:00:00.000Z
- Bethesda System for Reporting Cervical Cytology · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your Cervical Cancer Screen Panel test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book Cervical Cancer Screen Panel now